ZIOPHARM Oncology
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$79,976,000 over the previous period. Total operating expenses were $80,361,000.

Profit Margin

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP): Profit margin
2011 667K -63.77M -9561.92%
2012 800K -96.13M -12016.5%
2013 800K -57.10M -7138.38%
2014 1.37M -31.78M -2314.71%
2015 4.33M -120.08M -2772.11%
2016 6.86M -165.29M -2409.23%
2017 6.38M -54.32M -850.26%
2018 146K -53.11M -36381.51%
2019 0 -117.79M
2020 0 -79.97M

ZIOP Income Statement (2011 โ€“ 2020)

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue
Revenue
00146K6.38M6.86M4.33M1.37M800K800K667K
Cost of revenue
0000000000
Gross profit
00146K6.38M6.86M4.33M1.37M800K800K667K
Operating exp.
Research and development
52.69M38.33M34.13M45.08M157.79M106.78M32.70M42.85M83.44M57.08M
Selling and marketing
0000000000
Total operating expenses
80.36M57.85M54.05M59.88M172.16M124.43M44.87M58.51M102.96M72.06M
Operating income
-79.97M-117.79M-53.11M-54.32M-165.29M-120.08M-31.78M-57.10M-102.16M-71.4M
Other income (expenses), net
000000006.03M7.62M
Income before tax
-79.97M-117.79M-53.11M-54.32M-165.29M-120.08M-31.78M-57.10M-96.13M0
Income tax expense
0000000000
Net income
-79.97M-117.79M-53.11M-54.32M-165.29M-120.08M-31.78M-57.10M-96.13M-63.77M
Earnings per share
Basic EPS
-0.38-0.7-0.37-0.4-1.27-0.96-0.31-0.66-1.22-0.97
Diluted EPS
-0.38-0.7-0.37-0.4-1.27-0.96-0.31-0.66-1.22-0.97
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source